Norbert Weissmann
Weißmann, Norbert
VIAF ID: 503151246548144131979 (Personal)
Permalink: http://viaf.org/viaf/503151246548144131979
Preferred Forms
- 100 0 _ ‡a Norbert Weissmann
- 100 1 _ ‡a Weißmann, Norbert
4xx's: Alternate Name Forms (3)
Works
Title | Sources |
---|---|
Activation of TRPC6 channels is essential for lung ischaemia–reperfusion induced oedema in mice | |
Differential Alterations of the Mitochondrial Morphology and Respiratory Chain Complexes during Postnatal Development of the Mouse Lung | |
hydrogen-peroxide producing NADPH oxidase 4 does not limit neointima development after vascular injury in mice | |
Nox family NADPH oxidases: Molecular mechanisms of activation | |
Obstructive sleep apnea in a patient with the Melkersson-Rosenthal syndrome. | |
On-line measurement of nitric oxide generation in buffer-perfused rabbit lungs | |
Oral sildenafil as long-term adjunct therapy to inhaled iloprost in severe pulmonary arterial hypertension | |
Organizers and activators: Cytosolic Nox proteins impacting on vascular function. | |
Oxidative injury of the pulmonary circulation in the perinatal period: Short- and long-term consequences for the human cardiopulmonary system | |
Oxygen-dependent expression of cytochrome c oxidase subunit 4-2 gene expression is mediated by transcription factors RBPJ, CXXC5 and CHCHD2 | |
p38 MAPK Inhibition Improves Heart Function in Pressure Loaded Right Ventricular Hypertrophy | |
[Pathobiology, pathology and genetics of pulmonary hypertension: Recommendations of the Cologne Consensus Conference 2016]. | |
Pathophysiology and treatment of high-altitude pulmonary vascular disease. | |
The PDE inhibitor zaprinast enhances NO-mediated protection against vascular leakage in reperfused lungs. | |
Peroxisome proliferator-activated receptor-alpha reduces inflammation and vascular leakage in a murine model of acute lung injury | |
Pharmacokinetics and metabolism of infused versus inhaled iloprost in isolated rabbit lungs | |
Phosphodiesterase 10A upregulation contributes to pulmonary vascular remodeling | |
Phosphodiesterase 6 subunits are expressed and altered in idiopathic pulmonary fibrosis. | |
Post-stroke inhibition of induced NADPH oxidase type 4 prevents oxidative stress and neurodegeneration | |
Postnatal development of the bronchiolar club cells of distal airways in the mouse lung: stereological and molecular biological studies | |
Pressure Overload Creates Right Ventricular Diastolic Dysfunction in a Mouse Model: Assessment by Echocardiography. | |
Pressure overload leads to an increased accumulation and activity of mast cells in the right ventricle | |
Prevention of bleomycin-induced lung fibrosis by aerosolization of heparin or urokinase in rabbits | |
Pro-proliferative and inflammatory signaling converge on FoxO1 transcription factor in pulmonary hypertension | |
Prolonged vasodilatory response to nanoencapsulated sildenafil in pulmonary hypertension. | |
Pulmonale Hypertonie und schlafbezogene Atmungsstörungen | |
[Pulmonary arterial hypertension--a disease of the immune system?]. | |
Reactive Oxygen Species Differentially Modulate the Metabolic and Transcriptomic Response of Endothelial Cells | |
Redox-mediated signal transduction by cardiovascular Nox NADPH oxidases. | |
Redox signaling and reactive oxygen species in hypoxic pulmonary vasoconstriction | |
Regeneration von Lungenparenchym - eine Chance für die Zukunft | |
Response to: Comment on "Effect of Riociguat and Sildenafil on Right Heart Remodeling and Function in Pressure Overload Induced Model of Pulmonary Arterial Banding" | |
Response to Pagano et al. | |
[Reverse remodeling -- paradigm shift in the treatment of pulmonary hypertension] | |
Rhodiola: an ordinary plant or a promising future therapy for pulmonary hypertension? a brief review | |
The role of classical transient receptor potential channels in the regulation of hypoxic pulmonary vasoconstriction. | |
The role of dimethylarginine dimethylaminohydrolase in idiopathic pulmonary fibrosis | |
Role of Nox4 in murine models of kidney disease. | |
Role of Src tyrosine kinases in experimental pulmonary hypertension. | |
Sestrin-2, a repressor of PDGFRβ signalling, promotes cigarette-smoke-induced pulmonary emphysema in mice and is upregulated in individuals with COPD. | |
Sestrin 2 protein regulates platelet-derived growth factor receptor β (Pdgfrβ) expression by modulating proteasomal and Nrf2 transcription factor functions | |
Severe Emphysema in the SU5416/Hypoxia Rat Model of Pulmonary Hypertension | |
sGC activators and stimulators attenuate ischemia/reperfusion injury of the lung. | |
Shear force sensing of epithelial Na+ channel (ENaC) relies on N-glycosylated asparagines in the palm and knuckle domains of αENaC | |
Shroom expression is attenuated in pulmonary arterial hypertension. | |
Sildenafil for treatment of lung fibrosis and pulmonary hypertension: a randomised controlled trial | |
Sildenafil improves dynamic vascular function in the brain: studies in patients with pulmonary hypertension | |
Sildenafil in hypoxic pulmonary hypertension potentiates a compensatory up-regulation of NO-cGMP signaling | |
Simultaneous analysis of 4- and 5-series lipoxygenase and cytochrome P450 products from different biological sources by reversed-phase high-performance liquid chromatographic technique. | |
[Sleep apnea and cardiovascular disease--results from animal studies] | |
Smoking: Is it a risk factor for pulmonary vascular diseases? | |
The soluble guanylate cyclase stimulator riociguat ameliorates pulmonary hypertension induced by hypoxia and SU5416 in rats. | |
Sphingosine Kinase 1 Regulates Inflammation and Contributes to Acute Lung Injury in Pneumococcal Pneumonia via the Sphingosine-1-Phosphate Receptor 2. | |
Structural and functional prevention of hypoxia-induced pulmonary hypertension by individualized exercise training in mice. | |
Suppression of adrenomedullin contributes to vascular leakage and altered epithelial repair during asthma | |
Targeting cancer with phosphodiesterase inhibitors | |
TASK-1 potassium channel is not critically involved in mediating hypoxic pulmonary vasoconstriction of murine intra-pulmonary arteries | |
Therapeutic efficacy of TBC3711 in monocrotaline-induced pulmonary hypertension | |
Time course of cigarette smoke-induced changes of systemic inflammation and muscle structure. | |
Treprostinil inhibits the recruitment of bone marrow-derived circulating fibrocytes in chronic hypoxic pulmonary hypertension. | |
Unchanged NADPH Oxidase Activity in Nox1-Nox2-Nox4 Triple Knockout Mice: What Do NADPH-Stimulated Chemiluminescence Assays Really Detect? | |
Upregulation of NAD(P)H oxidase 1 in hypoxia activates hypoxia-inducible factor 1 via increase in reactive oxygen species | |
Urodilatin, a natriuretic peptide stimulating particulate guanylate cyclase, and the phosphodiesterase 5 inhibitor dipyridamole attenuate experimental pulmonary hypertension: synergism upon coapplication. | |
Vasculotide reduces pulmonary hyperpermeability in experimental pneumococcal pneumonia. | |
Vaskuläre Effekte der alveolären Hypoxie - Sensor- und Signaltransduktionsmechanismen | |
Vaskuläre Folgeerkrankungen bei obstruktiver Schlafapnoe | |
VEGF receptor inhibition as a model of pulmonary hypertension in mice | |
Zardaverine and aerosolised iloprost in a model of acute respiratory failure |